Kathryn M. Duesman
2023
In 2023, Kathryn M. Duesman earned a total compensation of $211K as Vice President of Clinical Affairs at Retractable Technologies, a 4% increase compared to previous year.
Compensation breakdown
| Bonus | $500 |
|---|---|
| Salary | $198,406 |
| Other | $12,050 |
| Total | $210,956 |
Duesman received $198.4K in salary, accounting for 94% of the total pay in 2023.
Duesman also received $500 in bonus and $12.1K in other compensation.
Rankings
In 2023, Kathryn M. Duesman's compensation ranked 2,678th out of 2,918 executives tracked by ExecPay. In other words, Duesman earned more than 8.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,678 out of 2,918 | 8th |
Division Manufacturing | 1,490 out of 1,608 | 7th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 233 out of 252 | 8th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 167 out of 184 | 9th |
Industry Surgical and Medical Instruments and Apparatus | 132 out of 144 | 8th |
Source: SEC filing on March 29, 2024.
Duesman's colleagues
We found four more compensation records of executives who worked with Kathryn M. Duesman at Retractable Technologies in 2023.
News
Retractable Technologies CEO Thomas Shaw's 2023 pay rises 7% to $1.1M
March 29, 2024
Retractable Technologies CEO Thomas Shaw's 2022 pay falls 91% to $1.1M
March 30, 2023
Retractable Technologies CEO Thomas Shaw's 2021 pay jumps 2,129% to $12M
March 31, 2022
Retractable Technologies CEO Thomas Shaw's 2020 pay rises 2% to $517K
March 31, 2021
Retractable Technologies CEO Thomas Shaw's 2019 pay rises 2% to $505K
March 30, 2020
Retractable Technologies CEO Thomas Shaw's 2018 pay rises 3% to $496K
March 28, 2019